Business Description
Jianmin Pharmaceutical Group Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE000001HB7
Compare
Compare
Traded in other countries / regions
600976.China IPO Date
2004-04-19Description
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.89 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.24 | |||||
| Interest Coverage | 82.93 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.18 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.7 | |||||
| 3-Year EBITDA Growth Rate | 59.1 | |||||
| 3-Year EPS without NRI Growth Rate | 64.7 | |||||
| 3-Year FCF Growth Rate | 205.9 | |||||
| 3-Year Book Growth Rate | 15.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.56 | |||||
| 9-Day RSI | 48.6 | |||||
| 14-Day RSI | 50.39 | |||||
| 6-1 Month Momentum % | 27.79 | |||||
| 12-1 Month Momentum % | 50.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 0.65 | |||||
| Days Inventory | 43.92 | |||||
| Days Sales Outstanding | 68.98 | |||||
| Days Payable | 92.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.39 | |||||
| Dividend Payout Ratio | 0.29 | |||||
| 3-Year Dividend Growth Rate | 59.1 | |||||
| Forward Dividend Yield % | 1.39 | |||||
| 5-Year Yield-on-Cost % | 8 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.07 | |||||
| Operating Margin % | 8.99 | |||||
| Net Margin % | 11.2 | |||||
| ROE % | 23.53 | |||||
| ROA % | 12.87 | |||||
| ROIC % | 18.59 | |||||
| ROC (Joel Greenblatt) % | 112.31 | |||||
| ROCE % | 24.96 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.09 | |||||
| PE Ratio without NRI | 26.09 | |||||
| Shiller PE Ratio | 66.4 | |||||
| Price-to-Owner-Earnings | 29.8 | |||||
| PEG Ratio | 0.71 | |||||
| PS Ratio | 2.96 | |||||
| PB Ratio | 5.6 | |||||
| Price-to-Tangible-Book | 5.74 | |||||
| Price-to-Free-Cash-Flow | 55.04 | |||||
| Price-to-Operating-Cash-Flow | 40.13 | |||||
| EV-to-EBIT | 22.07 | |||||
| EV-to-EBITDA | 22.07 | |||||
| EV-to-Revenue | 2.73 | |||||
| EV-to-FCF | 52.23 | |||||
| Price-to-Projected-FCF | 4.53 | |||||
| Price-to-Median-PS-Value | 1.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.04 | |||||
| Price-to-Graham-Number | 2.58 | |||||
| Price-to-Net-Current-Asset-Value | 10.85 | |||||
| Earnings Yield (Greenblatt) % | 4.5 | |||||
| Forward Rate of Return (Yacktman) % | 20.64 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Jianmin Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 3,736.244 | ||
| EPS (TTM) (Â¥) | 2.75 | ||
| Beta | 1.74 | ||
| Volatility % | 66.7 | ||
| 14-Day RSI | 50.39 | ||
| 14-Day ATR (Â¥) | 3.386924 | ||
| 20-Day SMA (Â¥) | 71.5895 | ||
| 12-1 Month Momentum % | 50.49 | ||
| 52-Week Range (Â¥) | 36.46 - 84.93 | ||
| Shares Outstanding (Mil) | 153.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jianmin Pharmaceutical Group Co Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jianmin Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jianmin Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Jianmin Pharmaceutical Group Co Ltd(SHSE:600976)'s stock price today?
The current price of SHSE:600976 is ¥71.83. The 52 week high of SHSE:600976 is ¥84.93 and 52 week low is ¥36.46.
When is next earnings date of Jianmin Pharmaceutical Group Co Ltd(SHSE:600976)?
The next earnings date of Jianmin Pharmaceutical Group Co Ltd(SHSE:600976) is .
Does Jianmin Pharmaceutical Group Co Ltd(SHSE:600976) pay dividends? If so, how much?
The Dividend Yield %  of Jianmin Pharmaceutical Group Co Ltd(SHSE:600976) is 1.39% (As of Today), Highest Dividend Payout Ratio of Jianmin Pharmaceutical Group Co Ltd(SHSE:600976) was 0.68. The lowest was 0.17. And the median was 0.36. The  Forward Dividend Yield % of Jianmin Pharmaceutical Group Co Ltd(SHSE:600976) is 1.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers